NCT04893889View on ClinicalTrials.gov

Substudy (NCT04456582): Noninvasive Assessment of Myocardial Stiffness by 2D-SWE Ultrasound Technique (Two-dimensional Shear Wave Elastography) in Patients With Amyloidosis and Fabry Disease.

NAUnknownINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

September 9, 2020

Primary Completion Date

August 31, 2021

Study Completion Date

March 30, 2022

Conditions
Fabry DiseaseAmyloidosis
Interventions
DIAGNOSTIC_TEST

Shear-wave elastography

Myocardial shear wave elastography to assess myocardial stiffness by non-invasively quantifying diastolic myocardial elasticity.

Trial Locations (1)

05403-900

RECRUITING

Instituto do Coração - Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo, São Paulo

Sponsors

Collaborators (1)

Pfizer
All Listed Sponsors
collaborator

Pfizer

INDUSTRY

lead

University of Sao Paulo General Hospital

OTHER

NCT04893889 - Substudy (NCT04456582): Noninvasive Assessment of Myocardial Stiffness by 2D-SWE Ultrasound Technique (Two-dimensional Shear Wave Elastography) in Patients With Amyloidosis and Fabry Disease. | Biotech Hunter | Biotech Hunter